Axon CEO ties pay to AI policing push as 70 tools emerge

Rick Smith, the chief executive who built Axon into a $30 billion law enforcement technology company, is betting his compensation on artificial intelligence becoming the centerpiece of modern policing.

Axon Chief Executive Rick Smith published a vision on June 28 tying his personal compensation to the company's AI-driven strategy, betting that machine learning tools will transform law enforcement as profoundly as the Taser did two decades ago.

"AI is the most important technology shift in policing since the introduction of the taser," Smith said in the vision piece, without disclosing specific compensation targets or performance metrics tied to the AI push.

The bet comes as a major new study from Northumbria University identified 70 AI tools already deployed, trialed, or under development across the criminal justice system in England and Wales — 27 of them live and roughly 34 at pilot or trial stage. More than half came from commercial vendors. The four-year PROBabLE Futures project, a £4.2 million initiative funded by Responsible AI UK and conducted in partnership with the universities of Glasgow, Northampton, Leicester, Newcastle and Cambridge, found the gap between ambition and accountability is widening faster than safeguards can keep up.

For Axon, the stakes are high. The company dominates the police body-camera and conducted-energy device market, with its Taser brand nearly synonymous with less-lethal law enforcement tools. Smith's compensation bet signals confidence that Axon can extend its hardware monopoly into software — a transition that, if successful, could expand its addressable market beyond the $1 billion-plus in annual revenue the company currently generates from hardware and cloud services.

The Accountability Gap Widens

The UK government formally launched PoliceAI on June 10 — a new national center hosted by the College of Policing and backed by £75 million of Home Office funding over three years — with a promise to put AI into the hands of all 43 forces in England and Wales. Early trials demonstrated the technology's potential: 800 hours of footage in a kidnapping case reviewed in three hours, producing an early guilty plea, and half a million e-books of data translated instantly, leading to the arrest of a serious organized crime gang.

Yet the Northumbria study, led by Dr. Temitope Lawal, a research fellow in law at Northumbria University, found that the principle of a "human in the loop" — widely cited as a safeguard against AI errors — often exists in name only, providing a false sense of assurance rather than genuine oversight. The research also identified a counterintuitive danger: as AI tools approach near-perfect accuracy, human reviewers may stop checking outputs, making rare errors more likely to go undetected. This risk compounds when AI systems are chained together in sequence, with each stage potentially inheriting and amplifying errors from the one before.

The report set out 26 recommendations directed at the Home Office, PoliceAI, the College of Policing, the Crown Prosecution Service, the judiciary, technology providers and the research community. They include independent national evaluation of AI tools beyond facial recognition, mandatory transparency requirements and public registries, stronger procurement standards, and better workforce training. PoliceAI has committed to a public-facing register of how forces use AI, with a first version expected in the autumn.

What It Means for Axon Investors

For Axon investors, the question is whether the company can navigate growing regulatory scrutiny while capturing the market opportunity. Axon trades at roughly 35 times forward earnings, a premium that reflects expectations for its software and AI transition. If Smith's AI bet succeeds, the company could capture recurring revenue from cloud-based evidence management, real-time transcription, and predictive analytics — services that carry higher margins than hardware sales. If regulators impose strict transparency requirements or independent evaluation mandates, Axon's first-mover advantage could be blunted by compliance costs and procurement delays.

This article is for informational purposes only and does not constitute investment advice.